A RANDOMIZED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DARATUMUMAB IN COMBINATION WITH CYCLOPHOSPHAMIDE, BORTEZOMIB AND DEXAMETHASONE (CYBORD) COMPARED WITH CYBORD ALONE IN NEWLY DIAGNOSED SYSTEMIC AL AMYLOIDOSIS
2016-001737-27AMILOIDOSIS AL (AMILOIDOSIS SISTÉMICA AL DIAGNOSTICADAFundación Jiménez DíazInvestigador: ASKARI ASKARI ELHAM
